Track NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s current assets ($780K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current assets for NRSNW is $780K as of December 2025. That compares with $4.4M in the prior-year period — down 82.3% year over year. Investors often review this figure alongside NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, NRSNW's current assets moved from $4.4M to $780K — a 82.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s operating scale or balance-sheet position.
A current assets figure of $780K for NRSNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting NRSNW's current assets ($780K), review year-over-year change from $4.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.